Approvals/CIMA-AEMPS/DESVENLAFAXINA NEURAXPHARM 50 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG

Approved

STANDARD

DESVENLAFAXINA NEURAXPHARM 50 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG

Neuraxpharm Spain S.L.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: b56715a0e4682480
Drug Cima Aemps Name: DESVENLAFAXINA NEURAXPHARM 50 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Register Number: 86785
Holder Company Name: Neuraxpharm Spain S.L.
Marketing Company Name: Neuraxpharm Spain S.L.
Authorization Date: 2022-04-04
Dosage Form: COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose: 50 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Neuraxpharm Spain S.L.

DESVENLAFAXINA BENZOATO

73,16 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Apr 4, 2022

Approval ID

b56715a0e4682480

Type

Standard